Company Filing History:
Years Active: 2006
Title: Simon Hör - Innovator in Cytokine Receptor Research
Introduction
Simon Hör is a notable inventor based in Munich, Germany. He has made significant contributions to the field of cytokine receptor research. His work focuses on the Class II cytokine receptor family, which plays a crucial role in immune response and signaling.
Latest Patents
Simon Hör holds a patent for the isolated cytokine receptor LICR-2. This invention relates to new members of the Class II cytokine receptor family, such as LICR-2. The new member binds to AK155 and mediates STAT activation. This discovery has potential implications for therapeutic applications in immunology.
Career Highlights
Simon Hör is affiliated with the Ludwig Institute for Cancer Research Limited. His work at this prestigious institution has allowed him to explore innovative approaches in cancer research and immunotherapy. His dedication to advancing scientific knowledge is evident in his research endeavors.
Collaborations
Throughout his career, Simon has collaborated with esteemed colleagues, including Jean-Christophe Renauld and Helmut Fickenscher. These collaborations have enriched his research and contributed to the advancement of the field.
Conclusion
Simon Hör is a prominent figure in cytokine receptor research, with a patent that highlights his innovative contributions. His work continues to influence the scientific community and offers promising avenues for future research and therapeutic development.